Osteopenia in Cftr-deltaF508 mice

Josée Paradis1, Martina Wilke, Christina K Haston

  • 1Meakins-Christie Laboratories, Department of Medicine, McGill University, Canada.

Abstract

Insights

Cystic fibrosis mouse models with the DeltaF508 mutation exhibit osteopenic bone disease. Bone volume is reduced due to thinner or fewer trabeculae in these models.

Area of Science:

  • Bone biology
  • Genetics
  • Pathology

Background:

  • Cystic fibrosis transmembrane conductance regulator (Cftr) gene knockout mice develop osteopenia.
  • The DeltaF508 mutation is the most common cause of cystic fibrosis in humans.

Purpose of the Study:

  • To investigate osteopenia in cystic fibrosis mouse models with the DeltaF508 Cftr mutation.
  • To assess the bone phenotype in adult FVB/N Cftr(tm1Eur) and C57BL/6 Cftr(tm1Kth) mice.

Main Methods:

  • Histology, densitometry, and quantitative imaging were used to measure bone disease.
  • Femora of adult FVB/N Cftr(tm1Eur) and C57BL/6 Cftr(tm1Kth) mice were analyzed relative to littermate controls.

Main Results:

  • C57BL/6 Cftr(tm1Kth) mice had shorter femurs and lower bone volume due to thinner trabeculae.
  • FVB/N Cftr(tm1Eur) mice also showed lower bone volume, attributed to significantly fewer trabeculae.
  • Osteoblast and osteoclast numbers did not differ between cystic fibrosis and control mice.

Conclusions:

  • Adult DeltaF508-Cftr cystic fibrosis mouse models display osteopenic bone disease.
  • The study confirms a link between the DeltaF508 Cftr mutation and bone loss in mice.